Dr. Gwin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-598-4333Fax+1 206-598-6963
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2010 - 2013
University of WashingtonResidency, Internal Medicine, 2006 - 2009
University of Alabama School of MedicineClass of 2006
Certifications & Licensure
WA State Medical License 2006 - 2025
NC State Medical License 2010 - 2015
Clinical Trials
Publications & Presentations
PubMed
- Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer.John B Liao, Nikita S Jejurikar, Katie M Hitchcock-Bernhardt, William R Gwin, Jessica L Reichow
Gynecologic Oncology. 2024-12-01 - TAILORing Estimates of Late Breast Cancer Recurrence with the RSClin Tool.William R Gwin, Nancy E Davidson
NEJM Evidence. 2024-08-01 - 34 citationsCombination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.Shinya Abe, Hiroshi Nagata, Erika J Crosby, Yoshiyuki Inoue, Kensuke Kaneko
Journal for Immunotherapy of Cancer. 2022-01-01
Press Mentions
YOUR HEALTH: Changing the Doses to Treat Aggressive Breast CancerFebruary 11th, 2021- Best Life: Alpha-TEA Strikes down Advanced Breast Cancer?December 15th, 2020
- Novel Breast Cancer Therapy Candidate Enters Clinical StudyAugust 26th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
